Loading stock data…
Waystar Holding Corp. (WAY)
$24.24-0.83 (-3.31%)
Market ClosedLast close Sep 8
Waystar Holding Corp.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Waystar Holding Corp. in the Healthcare sector is trading at $24.24 with a market capitalization of $4.8B. Wall Street consensus targets $33.30 (23 analysts), implying a +37.4% move over the next 12 months. The stock is currently 42% below its 52-week high of $41.47, remaining 4.1% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality. Risk note: MACD remains below its signal line. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +37.4% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $319.67M↑ | $313.87M↑ | $303.54M↑ | $268.65M↓ | $270.65M |
| Gross Profit | $221.99M↑ | $216.84M↑ | $210.90M↑ | $183.51M | $183.61M |
| Operating Income | $76.04M↓ | $80.47M↑ | $59.02M↓ | $60.23M↓ | $64.85M |
| Net Income | $40.87M↓ | $43.28M↑ | $19.99M↓ | $30.65M↓ | $32.18M |
Peer Comparison
JNJUNHPFE
Fundamentals
Waystar Holding Corp. develops a cloud-based software solution for healthcare payments. Its platform offers financial clearance, patient financial care, claim and payer payment management, denials prevention and recovery, clinical integrity and reven...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$4.75B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
35.40
Beta
Defensive asset. Lower volatility than the S&P 500.
0.06
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
3.38%
Volume
Today's trading volume
1.63M
Recent News
Waystar Reaffirms Long-Term Guidance, Lack of KPIs Disappoints, RBC Says
Waystar (WAY) management reaffirmed guidance for low-double-digit revenue growth and a 40% adjusted
Waystar Targets Autonomous Revenue Cycle With AI, Automation Push at Investor Day
Waystar (NASDAQ:WAY) outlined its strategy to expand its healthcare revenue-cycle-management platform through artificial intelligence, automation and broader adoption of its end-to-end product suite during its inaugural Investor Day in San Antonio. Chief Executive Officer Matt Hawkins said the comp
Waystar (WAY) Q2 2026 Earnings Call Transcript
Revenue hit $319.7 million with 18% growth as AI-powered solutions drive client expansion.
Waystar (WAY) Upgraded to Buy: What Does It Mean for the Stock?
Waystar (WAY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
WAY vs. ADSK: Which Stock Is the Better Value Option?
WAY vs. ADSK: Which Stock Is the Better Value Option?